Candidate vaccine by SII, Oxford varsity to join Ebola trial: WHO

The candidate vaccine developed by the Oxford University and the Serum Institute of India is among the two such vaccines added to the ongoing Ebola clinical trials, according to a World Health Organisation (WHO) statement, making it the first addition of candidate vaccines to the trials specifically targeting the Bundibugyo virus that has caused the current Ebola outbreak in the Democratic Republi
पूरी खबर मूल प्रकाशक की है। मुगल न्यूज़ हेडलाइन/सार दिखाता है और आपको स्रोत पर भेजता है।
पूरी खबर प्रकाशक साइट पर पढ़ें →